School of Medicine, University of Kansas Medical Center, Kansas City, Kansas. ORCID: https://orcid.org/0000-0001-6460-0230.
Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, Kansas.
J Opioid Manag. 2024 Jan-Feb;20(1):87-91. doi: 10.5055/jom.0851.
Tianeptine, an antidepressant and full µ-opioid receptor agonist, has increased in popularity and has been used as an over-the-counter supplement over the past decade. Due to its well-documented euphoric effects, there exists elevated risk for potential abuse. Buprenorphine-naloxone has been successfully utilized to treat opioid use disorder (OUD) in patients concurrently using tianeptine, limiting withdrawal symptoms and abstinence. However, there is limited evidence on the management of tianeptine use disorder, specifically methadone or naltrexone. The current opioid epidemic, the emerging use of tianeptine, and the lack of physician awareness have emphasized the need for further research on the role of tianeptine in medication-assisted treatment for OUD. This case report aims to demonstrate how medication-assisted therapy can be successfully utilized in a patient with opioid and severe other (tianeptine) drug use disorder.
四甲噻嗪,一种抗抑郁药和完全 μ 阿片受体激动剂,在过去十年中越来越受欢迎,并已作为非处方补充剂使用。由于其有充分记录的欣快作用,存在潜在滥用的风险增加。丁丙诺啡-纳洛酮已成功用于治疗同时使用四甲噻嗪的患者的阿片类药物使用障碍 (OUD),限制了戒断症状和禁欲。然而,关于四甲噻嗪使用障碍的管理,特别是美沙酮或纳曲酮,证据有限。目前的阿片类药物流行、四甲噻嗪的新用途以及医生意识的缺乏强调了进一步研究四甲噻嗪在 OUD 药物辅助治疗中的作用的必要性。本病例报告旨在展示药物辅助治疗如何可成功用于治疗阿片类药物和严重其他(四甲噻嗪)药物使用障碍的患者。